Delivery Order SPE2DB22D3102-SPE2DB25FL2UE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,367.34 to AmerisourceBergen Drug Corp for the supply of Daptomycin 500 mg vials. This contract, awarded on November 6, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 7, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award, reflecting the contractor's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,475.47 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Daptomycin 500 mg vials. This award is a firm fixed price contract with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Daptomycin 500 mg vials under a firm fixed price contract valued at $1,117.94. The delivery order, issued on May 30, 2025, carries an ultimate completion date of June 2, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,070.18 to AmerisourceBergen Drug Corp on November 3, 2025, with completion expected by November 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,929.29 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, effective November 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was competitively determined with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $8,107.13 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with a firm fixed price contract structure and an ultimate completion date of October 27, 2025. This is a competitive award with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $6,500.39 to AmerisourceBergen Drug Corp on October 28, 2025, under a firm fixed price, non-competitive arrangement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $80,543.27 to AmerisourceBergen Drug Corp for pharmaceutical products and supplies under a firm fixed-price contract. The award was made on November 3, 2025, with an ultimate completion date of the same day, and is classified as a non-set-aside competitive award. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,930.48 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This competitively awarded, firm fixed-price delivery order was issued on August 28, 2025, with an ultimate completion date of the same date. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,590.98 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, represents a competitively awarded, non-set-aside contract. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2UEDelivery Order
The Defense Logistics Agency awarded a $1,041.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 350 mg daptomycin vials, with an ultimate completion date of September 3, 2025. This non-competitive, non-set-aside delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for the company's federal deliveries. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen maintains significant federal contracting relationships with the Defense Logistics Agency and serves critical military and veteran healthcare systems. The parent IDC enables the company to supply a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related commodities across multiple therapeutic domains to support Department of Defense healthcare programs worldwide. Daptomycin, an injectable antibiotic used for serious bacterial infections, represents a typical component of the company's extensive medical product portfolio delivered through competitive federal procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/2/25 |